Skip to main content

Advertisement

Log in

Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

Computed tomography (CT) is current standard-of-care for preoperative staging in patients with invasive bladder cancer before radical cystectomy (RC). There are only sparse data on the association between preoperative CT findings and postoperative survival of patients.

Methods

We retrospectively evaluated preoperative CTs of 206 patients with invasive bladder cancer undergoing RC in an academic tertiary referral center. CTs were analyzed retrospectively for relative bladder wall thickness (BWT) and size of lymph nodes (LN). Associations between CT findings and risk of death from any cause (AC) as well as risk of death from bladder cancer (BC) were assessed by Kaplan–Meier estimates, cumulative incidence curves and multivariable Cox regression analysis.

Results

The median follow-up was 40 months. Increased BWT was significantly correlated with higher risk of death (AC: HR 1.68; p = 0.043; BC: HR 2.00; p = 0.027), as well as LN with a size of 6–10 mm (AC: HR 2.13; p = 0.002; BC: HR 2.77; p = 0.002) and >10 mm (AC: HR 2.47; p = 0.018; BC: HR 3.66; p = 0.007) when compared to LN ≤ 5 mm.

Conclusion

Our data showed a significant correlation of bladder wall thickness and LN size with the risk of death. Also lymph nodes >5 mm but ≤10 mm (resp. ≤8 mm)—usually considered non-pathologic—were associated with a significantly worse prognosis. This information can be used to counsel patients preoperatively. It might also be useful for a risk-adapted approach in regard to neoadjuvant chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Global Burden of Disease Study 2010 (GBD) (2010) Results by cause 1990–2010 (2010) Institute for Health Metrics and Evaluation, University of Washington. http://ghdx.healthmetricsandevaluation.org/sites/ghdx/files/record-attached-files/IHME_GBD_2010_COD_1990_2010.CSV. Accessed 19 Jul 2013

  2. Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A, European Associationof U (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792. doi:10.1016/j.eururo.2013.11.046

    Article  PubMed  Google Scholar 

  3. Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176(2):486–492. doi:10.1016/j.juro.2006.03.038 (discussion 482–491)

    Article  PubMed  Google Scholar 

  4. Tjokrowidjaja A, Lee C, Stockler MR (2013) Does chemotherapy improve survival in muscle-invasive bladder cancer (MIBC)? A systematic review and meta-analysis (MA) of randomized controlled trials (RCT). J Clin Oncol 31:(suppl; abstr 4544)

  5. Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402. doi:10.1159/000167836

    Article  PubMed  Google Scholar 

  6. Kim JK, Park SY, Ahn HJ, Kim CS, Cho KS (2004) Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 231(3):725–731. doi:10.1148/radiol.2313021253

    Article  PubMed  Google Scholar 

  7. Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663. doi:10.1111/j.1464-410X.2010.09212.x

    Article  PubMed  Google Scholar 

  8. Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038. doi:10.1016/j.eururo.2011.12.009

    Article  PubMed  Google Scholar 

  9. Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944

    CAS  PubMed  Google Scholar 

  10. Green DA, Durand M, Gumpeni N, Rink M, Cha EK, Karakiewicz PI, Scherr DS, Shariat SF (2012) Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU Int 110(10):1463–1470. doi:10.1111/j.1464-410X.2012.11129.x

    Article  PubMed  Google Scholar 

  11. Papalia R, Simone G, Grasso R, Augelli R, Faiella E, Guaglianone S, Cazzato R, Del Vescovo R, Ferriero M, Zobel B, Gallucci M (2012) Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases. BJU Int 109(7):1031–1036. doi:10.1111/j.1464-410X.2011.10446.x

    Article  PubMed  Google Scholar 

  12. Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ (2014) Prognostic value of C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. Urol Int 93(2):207–213. doi:10.1159/000357686

    Article  CAS  PubMed  Google Scholar 

  13. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M, European Associationof U (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653. doi:10.1016/j.eururo.2013.06.003

    Article  PubMed  Google Scholar 

  14. Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346

    Article  CAS  PubMed  Google Scholar 

  15. Team RC (2015) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria

    Google Scholar 

  16. Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA (2008) Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. BJU Int 101(8):969–972. doi:10.1111/j.1464-410X.2007.07335.x

    Article  PubMed  Google Scholar 

  17. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675

    CAS  PubMed  Google Scholar 

  18. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. doi:10.1016/j.ejca.2008.10.026

    Article  CAS  PubMed  Google Scholar 

  19. Barentsz JO, Engelbrecht MR, Witjes JA, de la Rosette JJ, van der Graaf M (1999) MR imaging of the male pelvis. Eur Radiol 9(9):1722–1736. doi:10.1007/s003300050916

    Article  CAS  PubMed  Google Scholar 

  20. Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321. doi:10.1016/j.urology.2012.01.040

    Article  PubMed  Google Scholar 

  21. Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M (2014) Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy. World J Urol. doi:10.1007/s00345-014-1465-4

    Google Scholar 

  22. Shariat SF, Karakiewicz PI, Godoy G, Lerner SP (2009) Use of nomograms for predictions of outcome in patients with advanced bladder cancer. Ther Adv Urol 1(1):13–26. doi:10.1177/1756287209103923

    Article  PubMed  PubMed Central  Google Scholar 

  23. Booth CM, Siemens DR, Li G, Peng Y, Tannock IF, Kong W, Berman DM, Mackillop WJ (2014) Perioperative chemotherapy for muscle-invasive bladder cancer: a population-based outcomes study. Cancer. doi:10.1002/cncr.28510

    PubMed  Google Scholar 

  24. Keegan KA, Zaid HB, Patel SG, Chang SS (2014) Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States. Curr Urol Rep 15(4):394. doi:10.1007/s11934-014-0394-5

    Article  PubMed  PubMed Central  Google Scholar 

  25. Reardon ZD, Patel SG, Zaid HB, Stimson CJ, Resnick MJ, Keegan KA, Barocas DA, Chang SS, Cookson MS (2014) Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol. doi:10.1016/j.eururo.2014.01.009

    PubMed  PubMed Central  Google Scholar 

Download references

Author contributions

Project development: SCS, TZ, KH, JEG, MR, TM. Data collection: SCS, TZ, TH, IM, AKS. Data analysis: SCS, TZ, KH, BH, TH, TM. Manuscript writing: SCS, TZ, BH. Manuscript revision/editing: TH, KH, AKS, JEG, MR, TM. Statistical analysis: SCS, BH, IM.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sebastian Christoph Schmid.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical standard

The study was conducted according to local and national regulations and approved by the local ethics committee.

Additional information

Sebastian Christoph Schmid and Tina Zahel have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmid, S.C., Zahel, T., Haller, B. et al. Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival. World J Urol 34, 569–576 (2016). https://doi.org/10.1007/s00345-015-1654-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-015-1654-9

Keywords

Navigation